All
Trodelvy Improves Quality of Life Over Chemo in TNBC
Trodelvy led to better disease control and improved quality of life compared to chemotherapy in patients with triple-negative breast cancer.
Keytruda Plus Chemo May Improve Penile Cancer Outcomes
Keytruda plus platinum-based chemotherapy appeared to be safe and effective in treating penile squamous cell carcinoma.
Advice from an Oncologist After a Cancer Diagnosis
When I came across an article with advice written by an oncologist for patients, I thought about his advice carefully.
Padcev Improves Outcomes for Cisplatin-Ineligible Bladder Cancer
For patients with cisplatin-ineligible bladder cancer, presurgical Padcev decreased the cancer stage without leading to delays in surgery.
Making the Most of Life Despite Having Stage 4 Cholangiocarcinoma
Even though I will never be cancer-free from cholangiocarcinoma, I’m ready to face the next chapter in my life and make the most of it.
Cholangiocarcinoma Drug Pulled From Market, Other Options Still Viable
While the FDA approval of Truseltiq for FGFR2-positive cholangiocarcinoma was withdrawn, there are still other viable treatment options, an expert said.
Let Your Friends Love You Enough During Cancer
Having a support system of loved ones truly helps during cancer.
Grief Advocate Explains the Difference Between Forced Joy and Toxic Positivity
After a cancer diagnosis, toxic positivity can be unhelpful, though forced joy may bring light to a difficult situation, a survivor and advocate said.
A Poem About Finding Purpose and Looking Ahead During Cancer
Learning that I had cancer — melanoma and renal cell carcinoma — made me feel like I lost something, but I keep looking ahead.
Opdivo Before and After Surgery Improves Event-Free Survival in NSCLC
Some patients with stage 3 non-small cell lung cancer saw benefits from Opdivo plus chemotherapy followed by surgery then Opdivo, researchers found.
Long-Term Postsurgical ADT May Reduce Prostate Cancer Metastasis Risk
Two years of postsurgical androgen deprivation therapy resulted in a 10-year metastasis-free survival rate of nearly 80%.
My Hereditary Breast Cancer Story
I believe I have hereditary cancer, especially after my daughter was approved to receive genetic testing for breast cancer.
Dato-DXd Improves Antitumor Intracranial Responses in NSCLC Subgroups
Dato-DXd was efficacious in patients with non-small cell lung cancer with brain metastases who have certain gene alterations, a phase 2 study showed.
Vaccine-Based Combo Shows Disease Control in CRC
PolyPEPI1018 may boost the efficacy of Tecentriq in certain patients with colorectal cancer.
Belamaf Regimen Improves Progression-Free Survival in Myeloma
Belamaf plus bortezomib and dexamethasone lengthened the time patients with relapsed or refractory myeloma lived before their disease got worse.
Bile Duct Cancer Continues to Respond to Zanidatamab, Per Longer Follow-Up
Zanidatamab continued to lead to responses and improved overall survival in pretreated HER2-positive biliary tract cancer.
Reblozyl Continues to Improve MDS Transfusion Independence
Patients with myelodysplastic syndromes tended to have longer periods of time without needing a red blood cell transfusion when treated with Reblozyl.
Experiencing a Type of Breast Cancer Déjà Vu
After a good friend told me about her recent diagnosis of breast cancer, I started experiencing a type of breast cancer déjà vu.
An Expert Breakdown of SurVaxM, the Novel Brain Cancer Vaccine
SurVaxM, which is being studied in gliobastoma, targets a certain protein that is found on the brain cancer cells.
Safety Profile of Lower-Dose Oral Onureg Remains Consistent in Lower-Risk MDS
The safety profile of 200 milligrams and 300 milligrams of oral Ongureg were similar in patients with lower- to intermediate-risk MDS.
Enhertu Boosts PFS in Pretreated, HR-Positive, HER2-Low and -Ultralow Breast Cancer
Enhertu lengthened the time to progression in patients with HR-positive, HER2-low or -ultralow metastatic breast cancer.
Chemo, Targeted Drugs Extremely Efficacious in HER2-Positive Breast Cancer
Presurgical paclitaxel, Herceptin and Perjeta showed “incredible efficacy” in treatment of HER2-positive breast cancer.
Perioperative Chemo Shows Longer Survival in Esophageal Cancer
Perioperative chemotherapy with chemotherapy led to improved survival outcomes versus neoadjuvant chemoradiation in resectable esophageal cancer.
Blenrep Combo Lengthens Time to Progression in Relapsed, Refractory Myeloma
Blenrep, Pomalyst and dexamethasone improved progression-free survival compared to Velcade, Pomalyst and dexamethasone in patients with relapsed/refractory myeloma.
Neoadjuvant Opdivo Plus Yervoy Provides ‘Excellent Responses’ in Stage 3 Melanoma
Opdivo plus Yervoy in the neoadjuvant setting reduced the risk for recurrence, progression or death, potentially offering patients with stage 3 melanoma a new standard of care.
Tagrisso Could Become Standard of Care for Some With EGFR+ NSCLC
Tagrisso following chemoradiotherapy improved progression-free survival compared with placebo in stage 3 EGFR-mutated non–small cell lung cancer.
Lymphadenectomy Didn’t Improve Progression, Survival in Ovarian Cancer
Researchers found that adding retroperitoneal lymphadenectomy to cytoreductive surgery did not improve survival among patients with advanced ovarian cancer.
Palliative Care via Telehealth Similarly Beneficial to Quality of Life in Lung Cancer
Researchers found telehealth care to deliver comparable quality-of-life benefits versus in-person visits among patients with advanced non-small cell lung cancer.
Posttreatment Imfinzi Sets New Standard for Small Cell Lung Cancer
For the first time in decades, a new regimen — consolidation Imfinzi after chemoradiation — improved outcomes in patients with limited-stage small cell lung cancer.
Rybrevant Plus Leclaza Has ‘Very Potent Activity’ in Lung Cancer Subset
Rybrevant plus Leclaza had promising response and progression-free survival rates in patients with EGFR-mutant non-small cell lung cancer.
